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The guinea pig is the laboratory animal par
excellence for the establishment of allergic con-
tact sensitization. Basic knowledge of this
form of delayed hypersensitivity has derived
almost exclusively from studies of this animal
using potent allergens such as dinitrochloro-
benzene and p-nitroso-dimethylaniline.
It is the consensus however that the guinea
pig is less sensitizable than the human. The key
difficulty is that some, perhaps many, sub-
stances which are known to be troublesome
human sensitizers have failed to sensitize the
guinea pig. These are generally weaker allergens
such as penicillin, neomyein, and heavy metals.
This deficiency seriously compromises the use-
fulness of this animal in screening new sub-
stances for their allergenic potentialities. On
the other hand, there seem to be no instances
in which a substance sensitizing the guinea pig
fails to do so in the human, It is obviously de-
sirable to use animals rather than humans in
preliminary screening but until false negative
results can be eliminated, guinea pig testing
cannot be relied upon to identify contact al-
lergens. Investigators have been much con-
cerned with closing the sensitivity gap between
the guinea pig and the human.
The Draize test (1, 2) recommended by the
U.S. Food & Drug Administration, is perhaps
the most widely used, especially by industries
producing new chemicals. Its fundamental de-
sign is that of Landsteiner & Jacobs (3) in
their renowned study of experimental contact
dermatitis. A series of ten intradermal injec-
tions is given on alternate days and the animals
challenged intraeutsneously two weeks after the
last injection. The literature does not contain
data which would enable one to appraise ac-
curately either its strengths or weaknesses,
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except for spoken judgements of too frequent
failures.
Divers efforts have been made to elevate the
sensitivity of the guinea pig. Chase (4) estab-
lished an exquisite degree of sensitivity to
pieryl chloride by his "combination" method.
First pierylated erythrocyte stromata in adju-
vant was injected, followed by a series of
weekly contact tests with pieryl chloride in
which each exposure progressively intensified
the degree of sensitivity. This procedure is
suitable for chemicals which can couple with
red blood cells; it is probably too cumbersome
for routine screening.
Voss (5) improved the Draize test by using
the highest concentration of the test agent that
was non-irritating instead of a fixed concen-
tration of 0.1%. Even so, of 44 mercaptans
studied, eleven sensitized men but failed in
guinea pigs.
Still better results were secured by Buehler
(6) who compared the Landsteiner intradermal
test to repeated topical applications by closed
patch. The animals were restrained for 6-hour
periods during the topical exposures. The supe-
riority of occlusive topical exposure was very
evident with a number of substances which did
not sensitize by injection: viz., tetraehloro-
salicylanilide, monobenzyl ether of hydroqui-
none, benzoeaine, thioglyeerol, and others.
However, sensitization to salts of mercury, co-
balt and nickel was not obtained though these
are well-known allergens in humans.
Chase and Maguire (7) have elaborated the
"combination" method into a "split adjuvant"
technique. Typically 5 sites are injected intra-
dermally with paraffin oil containing killed
tuberele bacilli. Each site is reinjected with the
allergen 24 hours later. A subsequent series of
patch tests boosts the sensitivity to a very
high level. Although these workers demon-
strated the possibility of inducing an exquisite
state of sensitization to dinitrochlorobenzene,
picrio acid, and picryl chloride, the prospect
they hold forth of using the split adjuvant
technique to identify contact allergens would
seem to be somewhat spoiled by their allusion
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to indifferent results obtained with weaker sen-
sitizers such as formaldehyde, penicillin, and
iodoform. However, the specifications of this
technique are not yet fixed and further modifi-
cations may well demonstrate an improved
capacity to detect weak allergens. Hood's
method (8) has apparently proved satisfactory
in an industrial setting (du Pont). The design
calls for thrice weekly topical applications for
9 exposures using the highest concentrations
which do not excessively irritate. The applica-
tions are made to abraded skin in half the test
group while all animals receive a total of 4
intradcrmal injections over a 3-week period.
We mounted an extensive research which
had the prime objective of enhancing the use-
fulness of the guinea pig in screening contact
allergens. The evolution of this work over an
8-year period has followed the tactics and
principles utilized in developing the maximiza-
tion test for identifying contact allergens in
humans (9, 10, 11, 12). The variables which
control the induction and elicitation of contact
sensitization have been studied quantitatively;
these results will he the subject of a forthcom-
ing monograph. The knowledge gained has been
combined into a test procedure which we now
consider highly reliable for detecting allergenic
chemicals.
The purposes of this paper arc: (1) to
provide specifications for the performance of
the guinea pig "maximization test", (2) to com-
pare the sensitivity of this procedure to that of
the Landstciner-Draize test and (3) to corre-
late the results of human and guinea pig maxi-
mization testing.
MATERIALs AND METHODS
Animol.s. Albino guinea pigs weighing 300-500
grams are used. It is important to avoid older
animals since they are appreciably less sensitiz-
able. While susceptibility is not influenced by sex,
we prefer females because of their greater tract-
ability. The combativeness of males often dam-
ages the test sites. Pregnant animals are entirely
unsuitable because of decreased capacity to man-
ifest an inflammatory reaction.
The standard outbred Hartley strain should
be used unless the investigator has empirically
verified the equivalent sensitizability of another
genotype. Although Chase (13, 14) and recently
Polák ef al. (15) have clearly demonstrated the
possibility of selecting genotypes with either in-
creased or decreased susceptibilities to specific
allergens, most breeds should be acceptable be-
cause the antigenic dose is extreme.
Though most of our basic studies have been
conducted on groups of 25 animals, it seems likely
that ten will generally suffice for preliminary
screening. If none become sensitized or, con-
versely, nearly all become allergic, one may con-
fidently certify the chemical to be a weak at best
or strong allergen, respectively. A result between
these extremes may justify expanding the sample
to secure more accurate appraisal.
Test substonces. The agents included substances
not known to sensitize humans: aluminum chlo-
ride, sodium lauryl sulfate and Tween 80, as
well as those which could be clinically rated as
strong sensitizers, e. p. formalin and streptomycin.
Most of the test agents have mild to moderate
allergenicity in man.
LAND5TETNER-DEAIzE (u-n) TEST
The same battery of allergens was tested by
the L-D method in order to compare the ef-
ficiency of the two procedures. The procedure
was as follows: A 0.1% solution or suspension
of the test material in saline was injected intra-
dermally into male albino guinea pigs of 300-.
500 grams. Injections of 0.1 ml were made
every other day or three times a week for a
total of ten, keeping the injections within a
field 3 to 4 ems square. The site was read 24
hours after each injection. Two weeks after the
10th injection, the animals were challenged by
an intradermal injection of 0.05 ml into a fresh
skin area. The animal was judged to be sen-
sitized if the reaction was clearly greater than
the average reaction of the inducing injections.
SPECIFICATIONS OF THE GUINEA PIG
(op.) MAxIMIzATION TEST
Preparation of Test Material
for Induction
A. Intradermal injections. Injections are
made with the allergen incorporated in
Frcund's adjuvant and also independently. It is
simplest to purchase Preund's Complete Adju-
vant; we have found that the Difco product'
gives results entirely comparable to the emul-
sion prepared according to Frcund's original de-
scription (16).
Immediately before injection the emulsion is
prepared by blending the commercial adjuvant
with an equal volume of water. The adjuvant
is placed in a container and the aqueous phase
is added in several installments while homoge-
nizing with a rotating stirrer. Water soluble
'Difco Laboratories, Detroit, Mich.
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allergens are first dissolved in the water phase;
oil soluble or insoluble chemicals are dissolved
or suspended in the adjuvant (a mixture of
paraffin oil and an emulsifier with mycobac
teria). The final concentration of the allergen
Fm. 1. induction. First stage. A row of three
mi ections are made on each side: (1) 0.1 ml of
adjuvant alone, (2) 0.1 ml of test substance
alone and (3) 0.1 ml of the test agent emulsified
in the adjuvant. The rectangle outlines the area
to which the test substance will be applied topi-
cally one week later.
is 5% by weight provided that the injection
does not produce local necrosis or ulceration
and is sufficiently free of systemic toxicity as
to not impair the health of the animal. Other-
wise, the concentration is adjusted to the
highest level that can be well tolerated locally
and generally; this will usually fall within the
1—5% range.
The allergen which is to be injected without
adjuvant is dissolved or suspended in an ap-
propriate vehicle, water if it is soluble in that
medium. Insoluble substances are incorporated
into either paraffin oil, peanut oil or propylene
glycol, whichever enables the best solution or
dispersion.
B. Topical application. Solids are finely pul-
verized and incorporated in petrolatum at 25%
concentration by weight if not excessively ir-
ritating or deleterious to general health. Other-
wise the concentration is the highest one which
produces a mild to moderate irritation.
Liquids are used at the highest concentration
which does not produce excessive inflammation,
undiluted if not irritating. Otherwise the con-
centration in petrolatum or water should be so
adjusted as to produce a mild to moderate ir-
ritation.
Induction Procedure
Induction is a two-stage operation. First, 3
pairs of injections are made simultaneously.
See Figs. 1 and 2. Second, closed patch ex-
posure is performed over the injection sites
Fro. 2. Induction. First stage. An area of 4 X 6 cm over the shoulders is clipped short
with an electric clipper. Into this area three pairs of symmetrical intradermal injections are
given simultaneously as diagrammed in fig. 1.
Fm. 3. Induction. Second stage Preparation of the patch. A 2 X 4 cm filter paper patch is
loaded with the test substance, backed successively by the impermeable plastic tape and the
elastic bandage.
rI®
L®
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one week later. See Figs. 3, 4 and 5. The
shoulder region is the induction site. An area
4 x 6 em is clipped short with an electric
clipper.
A. Intradermol injections. A row of 3 injec-
tions, six in all, are made on each side as fol-
lows: (1) 0.1 ml of the adjuvant without the
test agent, (2) 0.1 ml of test agent without
adjuvant and (3) 0.1 ml of the test substance
emulsified in complete adjuvant (Fig. 1). It
should be noted that the injection sites are
just within the boundaries of the 2 x 4 cm
patch, which will be applied one week later.
The adjuvant injections should he made deep
into the dermis to minimize sloughing.
B. Topical application. One week after the
injections the same area is clipped and shaved
closely with an electric razor. We find the Sun-
beam Shavemaster2 most suitable for the latter
operation. If the test agent is non-irritating,
the area is pretreated with 10% sodium lauryl
sulfate (SLS) in pctrolatum 24 hours before
the patch is applied. The SLS is massaged into
the skin with a glass rod without bandaging.
This concentration of SLS enhances sensitiza-
tion by provoking a mild inflammatory reac-
tion.
The test agent in petrolatum is spread over
a 2 x 4 em patch of Whatman No. 3MM filter
paper2 in a thick even layer or, if liquid, to
saturation. The patch is covered by an over-
lapping impermeable, plastic adhesive tape
(1½" 3M Blenderm4). This in turn is firmly
secured by elastic adhesive bandage (Tcnso-
plast5, 6.4 em in width), wound around the
torso of the animal. This dressing is left in
place for 48 hours (Figs. 3, 4 and 5).
It is expedient to prepare beforehand all the
occlusive bandage units required for one ses-
sion. Lengths of elastic bandage, about 25 cm
long, are cut and placed with the adhesive
surface up on the worktable. A 6 cm strip of
the impermeable plastic tape, adhesive side up,
is applied to one end of the elastic bandage.
Finally, the patch is placed centrally on the
plastic tape and loaded with the test substance.
With fluids, however, it is best to place the
2Model X 555 M, Sunbeam Electric Ltd., Ncr-
stone, East Kilbridge, Glasgow, Scotland.
3W. & R. Balston Ltd., Maidstone, England.
Mining & Manufacturing Co., St.
Paul, Minn.
P. J. Smith & Nephew Ltd., Hull & Welwyn
Garden City, England.
FIG. 4. Induction. The occlusive bandage unit
with tbe loaded patch is apphed over the sites in-jected a week earlier.
Fm. 5. lndu.ction. The occluded patch is firmly
secured by elastic adhesive bandage, wound around
the shoulder region of the animal and left in
place for 48 hours.
This study was conducted under the sponsor-
ship of the Swedish Medical Research Council(Project No. l9X-1036-Ol) and was supported, in
part, by funds from "Edvard Welanders stiftelse",
and "Riksforbundet mot allergi" (to B. Magnus-
son).
wetted patch directly on the skin and then
apply the Blenderm-Tensoplast covering.
Challenge Procedure
Challenge is by topical application. Provided
there is no irritation, solids are incorporated in
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Fio. 6. Challenge. The challenge test is performed on a 5 >< 5 cm chpped and shaved area
of the flank. The test agent is applied on a 2 H 2 cm piece of filter paper under a sealed
dressing as for induction.
FIG. 7. Challenge. The occluded patch is firmly secured by an encircling elastic adhesive
bandage for 24 hours.
petrolatum at 25% concentration and liquids
are used as is. Otherwise a sub-irritating con-
centration is empirically found which will not
cause redness in any of ten unexposed animals.
It is essential to avoid toxic concentrations in
order to eliminate false positive readings.
The animals are challenged two weeks after
the topical induction. Hair is removed from a
5 x 5 cm area on the flank by clipping and
shaving as before.
The test agent is apphed on a 2 x 2 em piece
of filter paper in the same fashion as for topical
induction. The patch is sealed to the flank for
24 hours under a 4 cm strip of 1½" Blenderm
(Fig. 6). This in turn is secured by Tens oplast
wound around the trunk (Fig. 7). The im-
portance of a secure dressing which affords
complete occlusion cannot be too strongly em-
phasized.
Reading of challenge reactions. The challenge
site is evaluated 24 hours after removal of the
patch. Any irritation produced by the plastic
tape will usually have subsided by then and the
allergic reaction will generally be at its peak.
The sites arc again examined in an additional
24 hours, mainly to detect weak, slowly de-
veloping reactions.
Three hours prior to the first reading, the
test site is shaved with the electric razor and
the skin gently cleansed of excess chemical with
ether. The readings are preferably made in
indoor daylight at noon. Artificial light
soureesG are obtainable which simulate "day-
light".
Redness constitutes the minimum criterion of
an allergic reaction. This presupposes of course
that identical tests on non-sensitized animals
cause na reaction. Uncertainty concerning the
validity of mild reactions may be reduced by
rechallenging within three to four days. His-
tologic examination can usually distinguish be-
tween allergic and irritant responses if doubt
still persists (17, 18). Strongly sensitized ani-
mals display a vivid redness, associated with
indurated swelling. If desired one can score the
reactions on a 4-point scale: no reaction, 0;
scattered mild redness, 1; moderate and diffuse
redness, 2; intense redness and swelling, 3. The
important statistic in maximization testing
however, is the frequency of sensitization not
intensity.
Rating of ollergenicity. Based upon the per-
centage of animals sensitized we assigned each
substance to one of five grades of allergenic
potency ranging from 0 to weak (I) to extreme
(V) (Table I). We could thus judge whether
the results of maximization testing were similar
in humans and guinea pigs.
RESULTS
Twenty-four substances of differing aller-
genicity were assayed by both procedures con-
o Manufactured by Macbeth Corporation, P.O.
Box 950, Newburgh, New York.
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TABLE I
Maximization grading
Sensitization
rate (%) Grade Classification
0—8 I Weak
9—28 II Mild
29—64 III Moderate
65—80 IV Strong
81—100 V Extreme
comitantly. The results are given in Table II.
There was a startling disparity between t.he
capabilities for identifying contact allergens.
Eleven known allergens (Benzocaine®, Mal-
athion®, mercaptobenzothiazole, mercuric
chloride, monobenzyl ether of hydroquinone,
neomycin, nickel sulfate, streptomycin, sul-
fathiazole, turpentine, and Vioform® failed to
sensitize a single animal by the L.-D. test.
Maximization testing readily identified these, a
majority of animals usually becoming sensi-
tized. Neither technique was successful with
lanolin and hexachlorophene, marginal sensi-
tizers at best. The maximization procedure un-
equivocally identified every clinically significant
allergen. No reactions were obtained with non-
allergens, viz, sodium lauryl sulfate, Tween 80
and aluminum chloride.
Table III compares the allergenicity grades
achieved by the L-D test with those of maxi-
mization testing in guinea pigs and humans.
TABLE II
Corn parizon of Landsteiner-Draize with maximization test
Maximization Test
Substance Induction Challenge
Sensitization
Landsteiner.
Sensitization
Intradermal
Concentration
in Adjuvant
Topical
Concentration
in Petrolatum
Topical
Concentration
in Petrolatum
Rate Rate
%
Acrylic monomer 5 5 10' 21/25 1/25
Aluminum chloride 2 25 2 0/25 0/25
Apresoline® 2 5 1 16/20 6/20
Atabrine® 1 25 10 18/20 5/20
Benzocaine® 2 25 5 7/25 0/25
Formalin 5 5* 2* 16/20 1/20
Hexachlorophene 5 25 1.5 0/25 0/25
Lanolin 5 25 15 0/25 0/25
Malathion® 10 10 20 13/24 0/20
Marfanil® 5 5 20 20/20 6/20
Mercaptobenzothiazole 1 25 15 8/20 0/20
Mercuric chloride 0.1 1 0.1* 8/25 0/25
Monobenzyl ether of hydroquinone 0.5 25 25 10/20 0/20
Neomycin 25 25* 25* .18/25 0/25
Nickel sulfate 5 5* 0.5* 11/20 0/20
Penicillin G 3 5 10 20/20 7/20
Potassium dichromate 1 1 0. 1* 18/24 3/20
Sodium lauryl sulfate 1 5 0.5 0/25 0/25
Streptomycin 10 10 0.5* 18/25 0/25
Sulfathiazole 5 25 10 9/25 0/25
Tetrachlorosalicylanilide 5 1 it 18/25 2/25
Turpentine 5 25 20 16/25 0/20
Tween 80 5 25 20 0/25 0/25
Vioform® 5 25 5 5/25 0/25
* vehicle H20.
t vehicle ethanol 70%.
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TABLE III
Grades of allergenic potency by the Landsteiner-Draize test, the maximization test in hu?nans
and the maximization test in guinea pigs
Substance
Landsteiner-Draize
Test
% pos. Grade
Guine
Maximiza
% pus.
a Pig
tion Test
Grade
Human Maximization
Test'
% poe. Grade
Acrylic monomer 4 I 84 V ND
Aluminum chloride 0 I 0 I 0 I
Apresoline® 30 III 80 IV 100 V
Atabrine® 25 II 90 V 78 IV
Benzocaine® 0 I 28 II 22 II
Formalin 5 I 80 IV 72 IV
Hexachlorophene 0 I 0 I 0 I
Lanolin 0 I 0 I 0 I
Malathion® 0 I 54 III 100 V
Marfanil® 30 III 100 V ND
Mercaptobenzothiazole 0 I 40 III 38 III
Mercuric chloride 0 I 32 III 92 V
Monobenzyl ether of hydroquinone 0 I 50 III 92 V
Neomycin 0 I 72 IV 28 II
Nickel sulfate 0 I 55 III 48 III
Penicillin G 35 III 100 V 67 IV
Potassium dichromate 15 II 75 IV 100 V
Sodium lauryl sulfate 0 I 0 I 0 I
Streptomycin 0 I 72 IV 80 IV
Sulfathiazole 0 I 36 III 4 I
Tetrachlorosalicylanilide 8 I 72 IV 88 V
Turpentine 0 1 64 III 72 IV
Tween80 0 I 0 I 0 I
Vioform® 0 I 20 II 0 I
1 Results from Kligman (1966d).
ND = not done.
The L-D test rated 14 substances as weak al-
lergens (Grade I) whereas 12 of these had
grades of II or more by maximization testing.
Moreover, no substance was graded higher than
III by the L-D test whereas fully 10 achieved
that status by the maximization test.
As regards maximization testing in guinea
pigs and humans, the results are remarkably
congruent (human data from Kligman (12)).
Agents which sensitized humans invariably
did so in the guinea pig. The quantitative
similarities are noteworthy. The ratings for the
two tests were within a single grade level for
18 of the test substances; for the other four
the discrepancy was two grades. Vioform®
sensitized guinea pigs but not man.
DISCUSSION
The guinea pig maximization procedure ap-
parently detects and rates allergenic substances
in a way comparable to that of the human
maximization assay. The procedure has proved
both specific and sensitive. In regard to sul-
fathiazole and Vioform® the G.P. test was even
more sensitive. The latter was entirely missed
in humans but achieved grade II status in
guinea pigs. Grade I for sulfathiazole on human
testing doubtless underrates its allergenic po-
tentiality; grade iii in guinea pigs seems more
in accord with clinical experience.
In a total experience which is larger than
the results presented here, specificity of the
test has been upheld. Guinea pigs do not be-
come sensitized to substances which do not
induce contact allergy in humans.
Although we are persuaded that the guinea
pig test can identify contact allergens as reli-
ably as the human, it is all too easy to make
misjudgements. If unwarranted conclusions are
to be avoided one must clearly understand what
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kind of decisions are permissible. Sound inter-
pretation requires both judgement and experi-
ence. Our views have been presented previ-
ously (12).
The aim of the test clearly defines its limita-
tions. It simply establishes to what extent a
particular substance has the potentiality for
acting as a contact sensitizer. It reveals that a
chemical possesses immunogenic capabilities but
the percentage of animals sensitized does not
indicate the probable human incidence of sen-
sitization. The antigenic stimulus in the test
procedure is enormously greater than under
conceivable conditions of use; this magnifica-
tion is necessary in order not to miss weak al-
lergens. Whereas the L-D test seriously under-
estimates the hazard by failing to identify fairly
potent sensitizers, the G.P. maximization test
may mislead the unforewarned into an over-
estimation of risk.
Actually there is one particular result which
is predictive and enables a rather firm estimate
of safety in use; this is when none of the ani-
mals becomes sensitized. This indicates an al-
lergenic potential so low that no imaginable
human exposure is likely to be attended by a
significant incidence of sensitization. We em-
phasize that it does not mean that the sub-
stance will never sensitize anyone but rather
that the probability of sensitization is very low.
Interpretation becomes more troublesome
when a high porportion of the animals becomes
allergic. Let it be stated forthwith that this
outcome does not necessarily compel one to
abandon interest in the substance. This result
merely warns the toxicologist of the possibility
of harmfulness. Whether the agent should be
discarded or studied further requires careful
consideration of many factors. These include
whether the material is to be nsed in high or
low concentration, whether for a short or long
period, xvhether it will be applied to normal or
diseased skin, whether it is likely to be leached
out of the product, whether its effects are so
unique and advantageous that even an appreci-
able risk is justified.
If a substance is found to be a potent aller-
gen but has virtues which merit continuing in-
terest, we would propose the following guide-
lines in estimating the hazard. Instead of the
chemical itself, it can be tested in the form and
concentration in which it will be actually used,
viz, as a cosmetic, a topical drug, a fabric
finisher, an insecticide, etc. The end product,
not the chemical itself, is assayed. If this results
in little or no sensitization, exaggerated expo-
sure testing in humans would be a likely next
step. One might apply the product five times
daily instead of once, or perhaps under occlu-
sion or in overly generous amounts to large
areas, or perhaps to skin deliberately damaged
by a chemical irritant. So varied are the ap-
plications of substances to human skin that one
cannot lay down the conditions of further test-
ing in anything more than general terms.
Such exaggerated use or stress testing pro-
vides a safety factor in deciding to go ahead
with commercial exploitation even if one or
more ingredients are known to be potent al-
lergens.
Finally, the timid should be apprised that
certain substances known to be moderate to
strong sensitizers by maximization testing are
in fact in widespread use. Examples of these are
neomyein, penicillin, streptomycin, Mala-
thion®, and p-phenylenediamine.
Res ipsa loquitur!
SUMMARY
A new procedure has been described, the
guinea pig maximization test, for identifying
contact sensitizers. Injections are given intra-
dermally with and without complete Freund's
adjuvant and one week later the test agent is
applied topically over the injection site. The
animals are challenged by patch test two weeks
later.
The sensitizing potentialities of about twenty
allergens of differing potencies were determined
concomitantly by the maximization and Land-
steiner-Draize procedures. The sensitivity of
the latter was quite low, eleven substances
failed to sensitize a single animal although
these were clearly allergenic by the maximiza-
tion test.
The results of maximization testing in the
guinea pig were quite comparable to humans.
Human allergens invariably sensitized the
guinea pig.
Guidelines are set forth for interpreting the
results and obtaining further data to estimate
the hazard of clinical sensitization in use.
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